Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia.
BMC Infect Dis
; 20(1): 543, 2020 Jul 25.
Article
in En
| MEDLINE
| ID: mdl-32711457
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Rifampin
/
Microbial Sensitivity Tests
/
Tuberculosis, Multidrug-Resistant
/
Nucleic Acid Amplification Techniques
/
Time-to-Treatment
/
Antibiotics, Antitubercular
/
Mycobacterium tuberculosis
Type of study:
Observational_studies
/
Risk_factors_studies
/
Screening_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
/
Europa
Language:
En
Journal:
BMC Infect Dis
Journal subject:
DOENCAS TRANSMISSIVEIS
Year:
2020
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom